<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Eline Vandael</style></author><author><style face="normal" font="default" size="100%">Katrien Latour</style></author><author><style face="normal" font="default" size="100%">Goossens, Herman</style></author><author><style face="normal" font="default" size="100%">Koen Magerman</style></author><author><style face="normal" font="default" size="100%">Nico Drapier</style></author><author><style face="normal" font="default" size="100%">Boudewijn Catry</style></author><author><style face="normal" font="default" size="100%">Versporten, Ann</style></author></authors><translated-authors><author><style face="normal" font="default" size="100%">Belgian Point Prevalence Survey Study Group</style></author></translated-authors></contributors><titles><title><style face="normal" font="default" size="100%">Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017.</style></title><secondary-title><style face="normal" font="default" size="100%">Antimicrob Resist Infect Control</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">point prevalence survey; healthcare-associated infections; antimicrobial use; acute care hospitals; Belgium</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2020</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">9</style></volume><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;&lt;b&gt;Background: &lt;/b&gt;The point prevalence survey of healthcare-associated infections (HAIs) and antimicrobial use organized by the European Centre for Disease Prevention and Control (ECDC-PPS) and the Global Point Prevalence Survey of antimicrobial consumption (Global-PPS) were simultaneously performed in Belgian acute care hospitals in 2017.&lt;/p&gt;

&lt;p&gt;&lt;b&gt;Methods: &lt;/b&gt;Belgian acute care hospitals were invited to participate in either the ECDC or Global-PPS. Hospital/ward/patient-level data were collected between September-December 2017. All patients present in the wards at 8 a.m. on the day of the PPS were included. The data of the ECDC and Global-PPS on antimicrobial consumption were pooled. Detailed data on HAIs were analysed for ECDC-PPS.&lt;/p&gt;

&lt;p&gt;&lt;b&gt;Results: &lt;/b&gt;Overall, 110 Belgian acute care hospital sites participated in the ECDC and Global-PPS (countrywide participation rate: 81.4%, 28,007 patients). Overall, a crude prevalence of patients with at least one antimicrobial of 27.1% (95% confidence interval (CI) 26.5-27.6%) was found. The most frequently reported indications were pneumonia (23.2%), urinary tract infections (15.2%) and skin and soft tissue infections (11.9%). The reason for antimicrobial use was recorded for 81.9% of the prescriptions, a stop/review date for 40.8% and compliance with local antibiotic guidelines for 76.6%. In the ECDC-PPS, the crude prevalence of patients with at least one HAI was 7.3% (95%CI 6.8-7.7%). Most frequently reported HAIs were pneumonia (21.6%) and urinary tract infections (21.3%).&lt;/p&gt;

&lt;p&gt;&lt;b&gt;Conclusions: &lt;/b&gt;HAI and antimicrobial use prevalence remained stable in comparison with the previous PPS (7.1% and 27.4% in 2011 and 2015, respectively). Belgian hospitals should be further stimulated to set local targets to improve antibiotic prescribing and reduce HAI.&lt;/p&gt;
</style></abstract></record></records></xml>